Cipher Pharmaceuticals Inc CPH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver
-
Cipher Pharmaceuticals to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024
Trading Information
- Previous Close Price
- CAD 13.28
- Day Range
- CAD 13.31–14.83
- 52-Week Range
- CAD 4.10–19.69
- Bid/Ask
- CAD 14.25 / CAD 14.88
- Market Cap
- CAD 371.80 Mil
- Volume/Avg
- 145,057 / 71,893
Key Statistics
- Price/Earnings (Normalized)
- 20.76
- Price/Sales
- 12.03
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 1.97%
Company Profile
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 6
- Website
- https://www.cipherpharma.com
Comparables
Valuation
|
Metric
|
CPH
|
300111
|
688553
|
|---|---|---|---|
Price/Earnings (Normalized) | 20.76 | — | 53.62 |
Price/Book Value | 2.88 | 4.60 | 1.31 |
Price/Sales | 12.03 | 8.97 | 4.86 |
Price/Cash Flow | 13.17 | 108.80 | 27.30 |
Price/Earnings
CPH
300111
688553
Financial Strength
|
Metric
|
CPH
|
300111
|
688553
|
|---|---|---|---|
Quick Ratio | 10.53 | 4.59 | 2.65 |
Current Ratio | 11.18 | 5.52 | 2.93 |
Interest Coverage | — | 5.84 | 12.08 |
Quick Ratio
CPH
300111
688553
Profitability
|
Metric
|
CPH
|
300111
|
688553
|
|---|---|---|---|
Return on Assets (Normalized) | 27.34% | −0.23% | 1.73% |
Return on Equity (Normalized) | 30.12% | −0.42% | 2.13% |
Return on Invested Capital (Normalized) | 27.63% | −1.53% | 1.32% |
Return on Assets
CPH
300111
688553
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Jpnmclzlvs | Xplp | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Zxrlywsx | Sqgss | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Rgtptqsm | Rkx | $48.4 Bil | |||
| Viatris Inc
VTRS
| Tbhxtnbym | Wcph | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Vtmywqrj | Kkmxk | $13.5 Bil | |||
| Catalent Inc
CTLT
| Zrmdzqch | Hfrcyxq | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Wcddbvvj | Rpshmy | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Mygwjjb | Nxhm | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Xmfdxpssv | Qrbb | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Tvftdjw | Ylrp | $2.3 Bil |
United States